Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Jan 5, 2026
Sale
Shares
10,135
Price
$15.17
Total Value
$153.75K
Shares Held After
624,403
% of Holdings
1.6%

Monte Rosa Therapeutics, Inc. (GLUE)

Dunn Edmund — Principal Accounting Officer
Jan 5, 2026
Sale
Shares
1,039
Price
$15.17
Total Value
$15.76K
Shares Held After
22,693
% of Holdings
4.4%

Monte Rosa Therapeutics, Inc. (GLUE)

Champoux Jennifer — Chief Operating Officer
Jan 5, 2026
Sale
Shares
2,629
Price
$15.17
Total Value
$39.88K
Shares Held After
62,371
% of Holdings
4.0%

Zymeworks Inc. (ZYME)

Moore Paul Andrew — Chief Scientific Officer
Jan 5, 2026
Sale
Shares
10,821
Price
$25.10
Total Value
$271.57K
Shares Held After
40,391
% of Holdings
21.1%

Zymeworks Inc. (ZYME)

Moore Paul Andrew — Chief Scientific Officer
Jan 5, 2026
Sale
Shares
9,289
Price
$25.10
Total Value
$233.13K
Shares Held After
31,212
% of Holdings
22.9%
Jan 5, 2026
Sale
Shares
31,686
Price
$25.10
Total Value
$795.22K
Shares Held After
193,266
% of Holdings
14.1%
Jan 5, 2026
Sale
Shares
22,657
Price
$25.10
Total Value
$568.62K
Shares Held After
158,286
% of Holdings
12.5%

Zymeworks Inc. (ZYME)

Smith Jeffrey T L — EVP & Chief Medical Officer
Jan 5, 2026
Sale
Shares
10,538
Price
$25.10
Total Value
$264.47K
Shares Held After
18,352
% of Holdings
36.5%
Jan 5, 2026
Sale
Shares
6,400
Price
$35.07
Total Value
$224.42K
Shares Held After
2,499,291
% of Holdings
0.3%
Jan 5, 2026
Sale
Shares
41,276
Price
$34.22
Total Value
$1.41M
Shares Held After
2,505,691
% of Holdings
1.6%
Jan 5, 2026
Sale
Shares
53,279
Price
$33.38
Total Value
$1.78M
Shares Held After
2,546,967
% of Holdings
2.0%
Jan 5, 2026
Sale
Shares
132,454
Price
$32.29
Total Value
$4.28M
Shares Held After
2,600,246
% of Holdings
4.8%

Viking Therapeutics, Inc. (VKTX)

Mancini Marianna — Chief Operating Officer
Jan 5, 2026
Sale
Shares
1,600
Price
$35.07
Total Value
$56.12K
Shares Held After
409,190
% of Holdings
0.4%

Viking Therapeutics, Inc. (VKTX)

Mancini Marianna — Chief Operating Officer
Jan 5, 2026
Sale
Shares
10,500
Price
$34.22
Total Value
$359.30K
Shares Held After
410,790
% of Holdings
2.5%

Viking Therapeutics, Inc. (VKTX)

Mancini Marianna — Chief Operating Officer
Jan 5, 2026
Sale
Shares
13,600
Price
$33.37
Total Value
$453.88K
Shares Held After
421,290
% of Holdings
3.1%

Viking Therapeutics, Inc. (VKTX)

Mancini Marianna — Chief Operating Officer
Jan 5, 2026
Sale
Shares
31,961
Price
$32.29
Total Value
$1.03M
Shares Held After
434,890
% of Holdings
6.8%

Viking Therapeutics, Inc. (VKTX)

ZANTE GREG — Chief Financial Officer
Jan 5, 2026
Sale
Shares
1,500
Price
$32.09
Total Value
$48.13K
Shares Held After
189,891
% of Holdings
0.8%

Viking Therapeutics, Inc. (VKTX)

ZANTE GREG — Chief Financial Officer
Jan 5, 2026
Sale
Shares
10,300
Price
$34.24
Total Value
$352.63K
Shares Held After
191,371
% of Holdings
5.1%

Viking Therapeutics, Inc. (VKTX)

ZANTE GREG — Chief Financial Officer
Jan 5, 2026
Sale
Shares
13,900
Price
$33.38
Total Value
$464.02K
Shares Held After
201,671
% of Holdings
6.4%

Viking Therapeutics, Inc. (VKTX)

ZANTE GREG — Chief Financial Officer
Jan 5, 2026
Sale
Shares
31,961
Price
$32.30
Total Value
$1.03M
Shares Held After
215,571
% of Holdings
12.9%

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Hamilton James C — Chief Medical Officer
Jan 5, 2026
Sale
Shares
309
Price
$68.00
Total Value
$21.01K
Shares Held After
171,958
% of Holdings
0.2%

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Hamilton James C — Chief Medical Officer
Jan 5, 2026
Sale
Shares
437
Price
$65.97
Total Value
$28.83K
Shares Held After
172,267
% of Holdings
0.3%

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Hamilton James C — Chief Medical Officer
Jan 5, 2026
Sale
Shares
1,200
Price
$64.49
Total Value
$77.39K
Shares Held After
172,704
% of Holdings
0.7%

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Hamilton James C — Chief Medical Officer
Jan 5, 2026
Sale
Shares
12,711
Price
$63.95
Total Value
$812.87K
Shares Held After
173,904
% of Holdings
6.8%

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Hamilton James C — Chief Medical Officer
Jan 5, 2026
Sale
Shares
14,792
Price
$63.01
Total Value
$932.04K
Shares Held After
186,615
% of Holdings
7.3%

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Hamilton James C — Chief Medical Officer
Jan 5, 2026
Sale
Shares
6,090
Price
$62.28
Total Value
$379.29K
Shares Held After
201,407
% of Holdings
2.9%
Shares
46
Price
$68.00
Total Value
$3.13K
Shares Held After
474,908
% of Holdings
0.0%
Shares
2,336
Price
$64.04
Total Value
$149.60K
Shares Held After
474,954
% of Holdings
0.5%
Shares
5,873
Price
$62.91
Total Value
$369.47K
Shares Held After
477,290
% of Holdings
1.2%
Shares
900
Price
$62.25
Total Value
$56.02K
Shares Held After
483,163
% of Holdings
0.2%
Shares
600
Price
$61.12
Total Value
$36.67K
Shares Held After
484,063
% of Holdings
0.1%
Shares
313
Price
$68.00
Total Value
$21.28K
Shares Held After
484,663
% of Holdings
0.1%
Shares
900
Price
$66.01
Total Value
$59.41K
Shares Held After
484,976
% of Holdings
0.2%
Shares
2,700
Price
$64.44
Total Value
$173.99K
Shares Held After
485,876
% of Holdings
0.6%
Shares
11,842
Price
$63.84
Total Value
$755.99K
Shares Held After
488,576
% of Holdings
2.4%
Shares
13,451
Price
$62.96
Total Value
$846.87K
Shares Held After
500,418
% of Holdings
2.6%
Shares
6,164
Price
$62.23
Total Value
$383.59K
Shares Held After
513,869
% of Holdings
1.2%
Shares
4,368
Price
$61.20
Total Value
$267.32K
Shares Held After
520,033
% of Holdings
0.8%
Jan 5, 2026
Purchase
Shares
198
Price
$42.98
Total Value
$8.51K
Shares Held After
447,331
% of Holdings
0.0%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
702
Price
$175.73
Total Value
$123.36K
Shares Held After
94,754
% of Holdings
0.7%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
655
Price
$174.28
Total Value
$114.15K
Shares Held After
95,456
% of Holdings
0.7%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
1,820
Price
$173.45
Total Value
$315.68K
Shares Held After
96,111
% of Holdings
1.9%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
286
Price
$171.92
Total Value
$49.17K
Shares Held After
97,931
% of Holdings
0.3%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
2,836
Price
$171.19
Total Value
$485.49K
Shares Held After
98,217
% of Holdings
2.8%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
3,205
Price
$170.61
Total Value
$546.81K
Shares Held After
101,053
% of Holdings
3.1%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Jan 5, 2026
Sale
Shares
2,799
Price
$169.29
Total Value
$473.84K
Shares Held After
104,258
% of Holdings
2.6%

Contineum Therapeutics, Inc. (CTNM)

Lorrain Daniel S. — Chief Scientific Officer
Jan 5, 2026
Sale
Shares
500
Price
$11.13
Total Value
$5.56K
Shares Held After
160,222
% of Holdings
0.3%

Maze Therapeutics, Inc. (MAZE)

Bernstein Harold — President, R&D & CMO
Jan 5, 2026
Sale
Shares
412
Price
$40.00
Total Value
$16.48K
Shares Held After
0
% of Holdings
100.0%

GALECTIN THERAPEUTICS INC (GALT)

Jamil Khurram — Chief Medical Officer
Jan 5, 2026
Sale
Shares
25,499
Price
$3.90
Total Value
$99.41K
Shares Held After
21,446
% of Holdings
54.3%

GALECTIN THERAPEUTICS INC (GALT)

CALLICUTT JACK W — Chief Financial Officer
Jan 5, 2026
Sale
Shares
25,732
Price
$3.90
Total Value
$100.30K
Shares Held After
27,968
% of Holdings
47.9%
Version: v26.3.33